Jean I. Liu

2012 - Halozyme Therapeutics

In 2012, Jean I. Liu earned a total compensation of $1.3M as Former Vice President, General Counsel and Secretary at Halozyme Therapeutics, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$55,500
Salary$300,000
Stock Awards$784,023
Other$144,002
Total$1,283,525

Liu received $784K in stock awards, accounting for 61% of the total pay in 2012.

Liu also received $55.5K in non-equity incentive plan, $300K in salary and $144K in other compensation.

Rankings

In 2012, Jean I. Liu's compensation ranked 5,154th out of 11,487 executives tracked by ExecPay. In other words, Liu earned more than 55.1% of executives.

ClassificationRankingPercentile
All
5,154
out of 11,487
55th
Division
Manufacturing
1,800
out of 4,253
58th
Major group
Chemicals And Allied Products
431
out of 1,203
64th
Industry group
Drugs
282
out of 925
70th
Industry
Biological Products, Except Diagnostic Substances
47
out of 165
72nd
Source: SEC filing on April 3, 2015.

Liu's colleagues

We found five more compensation records of executives who worked with Jean I. Liu at Halozyme Therapeutics in 2012.

2012

Gregory Frost

Halozyme Therapeutics

Chief Executive Officer

2012

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

2012

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2012

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

2012

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

News

You may also like